Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,978
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Fus knockdown inhibits the profibrogenic effect of cardiac fibroblasts induced by angiotensin II through targeting Pax3 thereby regulating TGF-β1/Smad pathway

Guoqiang Wanga Department of Cardiology, Chongqing Kanghua Zhonglian Cardiovascular Hospital, Chongqing, ChinaView further author information
,
Hong Wub Department of Obstetrics and Gynecology, The People’s Hospital, Chongqing, ChinaView further author information
,
Peng Liangc Department of Cardiology, The People’s Hospital, Chongqing, ChinaView further author information
,
Xiaojiao Hec Department of Cardiology, The People’s Hospital, Chongqing, ChinaView further author information
&
Dong Liuc Department of Cardiology, The People’s Hospital, Chongqing, ChinaCorrespondence[email protected]
View further author information
Pages 1415-1425 | Received 02 Feb 2021, Accepted 13 Apr 2021, Published online: 25 Apr 2021

References

  • Zimetbaum P. Atrial fibrillation. Ann Intern Med. 2017;166(5):Itc33–itc48.
  • Bhatt HV, Fischer GW. Atrial fibrillation: pathophysiology and therapeutic options. J Cardiothorac Vasc Anesth. 2015;29(5):1333–1340.
  • Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015;25(6):475–484.
  • Dzeshka MS, Lip GY, Snezhitskiy V, et al. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66(8):943–959.
  • Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. Jama. 2014;311(5):498–506.
  • Zhang W, Song S, Liu F, et al. Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose level: involvement of AngII-TGF-β1 pathway. Peptides. 2015;70:37–44.
  • Abd El-Rahman SS, Fayed HM. Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat. J Tissue Eng Regen Med. 2019;13(12):2131–2141.
  • Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51(8):802–809.
  • Ge Z, Chen Y, Wang B, et al. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway. J Mol Cell Cardiol. 2020;139:164–175.
  • Chen C, Ding X, Akram N, et al. Fused in sarcoma: properties, self-assembly and correlation with neurodegenerative diseases. Molecules. 2019;24(8):1622.
  • Lai L, Xu Y, Kang L, et al. LncRNA KCNQ1OT1 contributes to cardiomyocyte apoptosis by targeting FUS in heart failure. Exp Mol Pathol. 2020;115:104480.
  • Luo X, He S, Hu Y, et al. Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4. Cardiovasc Pathol. 2019;42:21–29.
  • Zeng K, Xie W, Huang J, et al. PAX3 silencing inhibits prostate cancer progression through the suppression of the TGF-β/Smad signaling axis. Cell Biol Int. 2020;44(10):2131–2139.
  • Wu H, Zhao ZA, Liu J, et al. Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction. Gene Ther. 2018;25(8):511–523.
  • Simões E Silva AC, Silveira KD, Ferreira AJ, et al. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013;169(3):477–492.
  • Park S, Nguyen NB, Pezhouman A, et al. Cardiac fibrosis: potential therapeutic targets. Transl Res. 2019;209:121–137.
  • Ravassa S, Ballesteros G, López B, et al. Combination of circulating type I collagen-related biomarkers is associated with atrial fibrillation. J Am Coll Cardiol. 2019;73(12):1398–1410.
  • Ma ZG, Yuan YP, Wu HM, et al. Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci. 2018;14(12):1645–1657.
  • Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76–83.
  • Buckingham M, Relaix F. PAX3 and PAX7 as upstream regulators of myogenesis. Semin Cell Dev Biol. 2015;44:115–125.
  • Katoh M. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review). Int J Mol Med. 2018;42(2):713–725.
  • Yang G, Li Y, Nishimura EK, et al. Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol Cell. 2008;32(4):554–563.
  • Moustakas A. TGF-beta targets PAX3 to control melanocyte differentiation. Dev Cell. 2008;15(6):797–799.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.